Evidence map›Paper›PMID 36737374›Full record

ArticleJournal of thrombosis and haemostasis : JTH2023

Corrigendum to GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis [J Thromb Haemost. 2021 Oct;19(10):2612-2617].

Karyn Megy, Kate Downes, Marie-Christine Morel-Kopp, José M Bastida, Shannon Brooks, Loredana Bury, Eva Leinoe, Keith Gomez, Neil V Morgan, Maha Othman and 6 more

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 13 institutions in 12 countries.

Karyn MegyDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; NIHR BioResource, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, UK.
Kate DownesDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; NIHR BioResource, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, UK; East Genomic Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Marie-Christine Morel-KoppDepartment of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia; Northern Blood Research Centre, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia.
José M BastidaDepartment of Hematology, IBSAL-Hospital Universitario de Salamanca, Salamanca, Spain.
Shannon BrooksInternational Society on Thrombosis and Haemostasis (ISTH), Carrboro, North Carolina, USA.
Loredana BurySection of Internal and Cardiovascular Medicine, Department of Medicine, University of Perugia, Perugia, Italy.
Eva LeinoeDepartment of Haematology, Rigshospitalet, National University Hospital, Copenhagen, Denmark.
Keith GomezHaemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, UK.
Neil V MorganInstitute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Maha OthmanBiomedical and Molecular Sciences School of Medicine Queen's University, Kingston, Ontario, Canada; School of Baccalaureate Nursing, St. Lawrence College, Kingston, Ontario, Canada; Clinical Pathology Department, Faculty of Medicine, Mansoura University, Egypt.
Willem H OuwehandDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; NIHR BioResource, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, UK; East Genomic Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Juliana Perez BoteroDivision of Hematology/Oncology, Medical College of Wisconsin and Versiti Diagnostic Laboratories, Milwaukee, Wisconsin, USA.
José RiveraServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER-U765, Murcia, Spain.
Harald SchulzeInstitute of Experimental Biomedicine, University Hospital Wuerzburg, Wuerzburg, Germany.
David-Alexandre TrégouëtINSERM UMR_S 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.
Kathleen FresonDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.
University of Cambridge · GBCentro Regional de Hemodonación · ESInstituto de Investigación Biomédica de Salamanca · ESKU Leuven · BEMansoura University · EGMedical College of Wisconsin · USRigshospitalet · DKRoyal Free London NHS Foundation Trust · GBThe University of Sydney · AUUniversitätsklinikum Würzburg · DEUniversité de Bordeaux · FRUniversity of Birmingham · GBUniversity of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36737374
PMCPMC10501975
OpenAlexW4318833487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.